Project information
Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
- Project Identification
- MSM0021622430
- Project Period
- 1/2007 - 12/2013
- Investor / Pogramme / Project type
-
Ministry of Education, Youth and Sports of the CR
- Research Intents
- MU Faculty or unit
- Faculty of Medicine
- Other MU Faculty/Unit
- Faculty of Science
- Other MU Faculty/Unit
- Faculty of Informatics
- Other MU Faculty/Unit
- Central European Institute of Technology
- Keywords
- embryonic stem cells
The goal of this project will be a) to profit from availability of unique cellular resources - mouse and human embryonic stem cells and normal and malignant hematopoietic stem/progenitor cells, b) to effectively employ a wide variety of current and complementary methodologies available to the consortium, and c) to exploit a proven/certified expertise in working with various living systems that span from in vitro cultured cells, through animal models to oncohematological patients. All this together will represent a powerful experimental platform aimed at addressing a nature of molecules and molecular mechanisms underlaying phenomena that are common to both normal and cancer stem cells, mainly their ability to self-renew and to enter differentiation pathways. Integral part of this general goal is to implement multifaceted analytical approach that will cover studies of gene expression at both mRNA and protein levels, evaluating function of extra and intracellular signaling pathways, and analyzing biological properties of cells in vitro and in vivo. Expected outcome will be not only understanding but also a definition of molecules and/or molecular pathways to be tested as therapeutic targets, and cellular models that will make such testing feasible.
Publications
Total number of publications: 359
2007
-
Potentional biomarkers for early detection of Graft-versus-host disease.
Year: 2007, type: Conference abstract
-
Prognostický význam mutačního stavu genu TP53 u pacientů s B-buněčnou chronickou lymfocytární leukémií – význam monitorování obou alel
III. dny diagnostické, prediktivní a experimentální onkologie, year: 2007
-
Reakce štěpu proti hostiteli po alogenní transplantaci kostní dřeně a její predikce proteomickými přístupy.
Year: 2007, type: Conference abstract
-
Simple, mammalian cell-based assay for identification of inhibitors of the ErkMAP kinase pathway.
Investigational New Drugs, year: 2007, volume: 25, edition: 4, DOI
-
Sledování exprese vybraných genů u pacientů s B-buněčnou chronickou lymfocytární leukémií – záchyt změny dominantního leukemického klonu vlivem terapie.
III. dny diagnostické, prediktivní a experimentální onkologie, year: 2007
-
Stanovení chimérismu pomocí polymerázové řetězové reakce v reálném čase. Přehled a první vlastní zkušennosti
Transfúze a hematologie dnes, year: 2007, volume: 13, edition: 2
-
The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia.
Journal of Leukocyte Biology, year: 2007, volume: 82, edition: 6, DOI
-
The Frizzled family of unconventional GPCRs
Trends in Pharmacological Sciences, year: 2007, volume: 28, edition: 10
-
TransMap Viewer
Year: 2007